Serum level IL-6 has been identified as prognostic marker in many types of cancer, including ovarian cancer [35], prostate cancer [36], breast cancer [14], colon cancer [37], melanoma [38] and HNSCC [16]. This evidence concerns the gene IL6 and malignant colon neoplasm.